Extraosseous Ewing Sarcoma: Diagnosis, Prognosis and Optimal Management

Area of Science:

• Oncology
• Pathology

Background:

• Extraosseous Ewing sarcomas (EESs) are rare soft tissue tumors.
• EES patient characteristics and outcomes differ from skeletal Ewing sarcoma.
• Multimodality therapeutic strategies are recommended for the Ewing tumor family.

Purpose of the Study:

• To review the clinical presentation, diagnosis, and treatment of Extraosseous Ewing Sarcomas.
• To highlight the differences between EES and skeletal Ewing sarcoma.
• To discuss current and potential future therapeutic strategies for EES.

Main Methods:

• Review of existing literature on Extraosseous Ewing Sarcomas.
• Analysis of diagnostic tools including imaging and histopathology.
• Evaluation of treatment outcomes for surgery, chemotherapy, and radiotherapy.

Main Results:

• Clinical presentation of EES varies by primary tumor site.
• Diagnostic tools include imaging (ultrasound, CT, MRI) and tissue examination.
• Neoadjuvant chemotherapy shows more promise than adjuvant regimens for localized disease.
• Systematic chemotherapy improves survival in metastatic or recurrent EES.

Conclusions:

• EES requires a multimodality approach, with surgery as the primary treatment for localized disease.
• Chemotherapy, particularly neoadjuvant regimens, can improve survival.
• Radiotherapy is an option for local control but has associated complications.
• Further prospective studies are needed to validate biomarkers and optimize treatment strategies.